For insulin consumption, we recorded intraoperative, POD 0, POD 1, and POD 2 periods.
Immediate postoperative outcomes (ICU stay, myocardial injury/infarction, wound infection, sepsis, stroke, and death) were collected. We used criteria of increasing of postoperative troponin T >20% and >10 times of preoperative level as an indication for myocardial injury and infarction,[18 (link)] in which blood samplings were drawn at admission and ICU arrival. Also, we monitored side effects, nausea, and vomiting before induction, POD1, and POD2.
Immediate postoperative outcomes (ICU stay, myocardial injury/infarction, wound infection, sepsis, stroke, and death) were collected. We used criteria of increasing of postoperative troponin T >20% and >10 times of preoperative level as an indication for myocardial injury and infarction,[18 (link)] in which blood samplings were drawn at admission and ICU arrival. Also, we monitored side effects, nausea, and vomiting before induction, POD1, and POD2.
